Frequently asked questions What GLP1 medications does Ro offer
FDA regulatory status - compounded GLP-1s: FDA proposed April 30, 2026 to exclude semaglutide and tirzepatide from 503B Bulks List
Its particularly effective for areas like the face, neck, and jawline: perfect for combating that Ozempic face phenomenon where rapid facial fat loss leads to a hollowed, sunken appearance
Stainless steel vial cases For researchers and users who carry multiple vials, stainless steel cases with individual slots provide excellent physical protection
Sudden discontinuation carries a risk of rebound seizures or status epilepticus
Quick answer: The best GLP-1 injection sites are areas with enough fatty tissue for safe, effective absorption, like the abdomen, thigh, and upper arm